Healthcare -
Biotechnology - NASDAQ - US
$ 2.01
8.65 %
$ 166 M
Market Cap
-1.3
P/E
Price Target
Average
497.01%
Revenue Forecast
Estimate
10.32%
EBIT
Estimate
--24.19%
Net Income
Estimate
--1.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sutro Biopharma, Inc.
Wall Street analysts predict an average 1-year price target for STRO of $12 , with forecasts ranging from
a
low of
$8 to a high of $18 .
STRO Lowest Price Target
Wall Street Target
8 USD
298.01%
STRO Average Price Target
Wall Street Target
12 USD
497.01%
STRO Highest Price Target
Wall Street Target
18 USD
795.52%
REVENUE FORECAST
Revenue Forecast Chart STRO
EBIT FORECAST
EBIT Forecast Chart STRO
NET INCOME FORECAST
Net Income Chart STRO